We analyzed and confirmed the binding of KPNA2 to ISG15 and its ISGylation by mass spectrometry and experiments, and further identified KPNA2 as the mediator of ISG15 in modulating the cancer stem-like characteristics of ATC. This evidence concerns the gene KPNA2 and cancer.